PP53. PREFERENTIAL LOCALIZATION OF LOW GRADE GLIOMAS WITH INCREASED MGMT AND P53 EXPRESSION
EREN P.1, Uyar S.2, Kılıç T.3, Topuzoğlu A.4, Erdağ B.5, Sav A2, Pamir M.N 3, Çırakoğlu B1 1. Marmara University Department of Medical Biology and Genetics 2. Marmara University Institute of Neurological Sciences Department of Pathology, 3. Marmara University Department of Neurosurgery, 4. Marmara University Department of Public Health, 5. Scientific and Technical Research Council of Turkey, Marmara Research Center e-mail: pinaren@yahoo.com; pinaren@gmail.com
*Corresponding Author:
page: 71

Abstract

Anatomical localization of gliomas are important for surgical excision of the tumour mass totally. The most important factor effecting prognosis is left tumour tissue mass that is effected by the localization and its total excision is only possible when the tumour is suitable for surgical intervention. Low grade gliomas are preferentially located at the secondary motor areas and especially oligodendrogliomas are located at the frontal and temporal lobes. Fourtyeight cases of this study were composed of 12 Astrocytomas, 16 Oligodendrogliomas and 20 Oligoastrocytomas histopathologically and 22 patients of the total group had p53 mutations. P53 protein expression of all three histopathological groups has found to be increased in mutation positive specimens than in non-mutated specimens at a statistically significant level. In this study the tumours having high MGMT expression those expected to be chemoresistant are located mostly at the parietal and temporal regions (p=0.029). The tumours with increased p53 exspression preferentially were located at the frontal and temporal lobes (p=0,014). With the detection of MGMT and p53 expression at the glial tissue, anticipation of theraphy modality and prognosis of the patients could be possible. Key Words; Localization of low grade gliomas, MGMT expression, p53 expression, prognosis.




Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006